← Leaderboards
Rodney Hunter
Texas Southern University
$74,246
Attributed
$74,246
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $38.1K · FY2023–24$50K$37.5K$25K$12.5K$0
'23
'24
Funding mix
By agency
NIH$74,246 · 1
By mechanism
P20$74,246 · 1
Top collaborators
No co-investigators on record.
Most similar at Texas Southern University
Same institution · by research overlap
- Huan Xie$1,984,233
- Dong Liang$2,756,902
- Adebayo O. Oyekan$6,825,377
- Omonike Arike Olaleye$796,644
- Veronica B. Ajewole$2,599,999
Others in their field
Other Rising Stars on “Adherence”
- Dennis Eyler · Fisher Bioservices, Inc.$16,341,540
- Matthew Morrow Engelhard · Duke University$7,519,665
- Andrew Gardiner · Libero Pharma Limited$6,351,015
- Richard Schrock · Fisher Bioservices, Inc.$5,879,422
- Christopher J. Lindsell · Vanderbilt University Medical Center$5,384,363
- Charles Daniel Meyers · Tempero Bio, Inc.$5,310,920
Research focus
AdherenceDocumentationAffectAmericanAfrican AmericanDisparityAtlasesAwarenessBreast Cancer Cell LineBreast Cancer PatientBreast Cancer TherapyBreast Cancer TreatmentCancer EtiologyCancer GenomicsCdk4 GeneCessation Of LifeCodeComputer ModelsDatabasesDeath RateDecision MakingDesignDifferential ExpressionDrug Resistance Pathway
Grant awards (2)
Impact of race and ethnicity on outcomes in patients with hormone receptor-positive breast cancer treated with CDK4/6 inhibitors$36,171
P20 · FY2024 · CA · contact PI
Impact of race and ethnicity on outcomes in patients with hormone receptor-positive breast cancer treated with CDK4/6 inhibitors$38,075
P20 · FY2023 · CA · contact PI